J&J Seeks Emergency Use Authorization for its One-Shot COVID-19 Vaccine
Johnson & Johnson (J&J) has applied for an Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its one-shot COVID-19 vaccine, which has shown 66% efficacy in preventing moderate to severe…